Clinical Trials Browser

Phase 1 × Has results × Leukemia-Lymphoma, Adult T-Cell × Clear all

NCT02689453 2022-04-29

Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)

Phase 1 Completed

11 enrolled 16 charts

DermatologicLymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT00355472 2012-10-18

Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL

Phase 1 Completed

16 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Peripheral